Review
doi: 10.1586/14737140.1.2.301.
Pharmacogenetics of cytotoxic drugs
Affiliations
- PMID: 12113035
- DOI: 10.1586/14737140.1.2.301
Item in Clipboard
Review
Pharmacogenetics of cytotoxic drugs
Expert Rev Anticancer Ther.
2001 Aug.
Abstract
The main genetic polymorphisms affecting the metabolism and transport of cytotoxic drugs are discussed in this review. Likely future approaches to pharmacogenetics and emerging technologies, such as tumor classification using microarray analysis, are also considered.
Similar articles
-
Pharmacogenetics in cancer etiology and chemotherapy.Clin Cancer Res. 1997 Jul;3(7):1025-30. Clin Cancer Res. 1997. PMID: 9815780 Review. No abstract available.
-
Introduction.Invest New Drugs. 2005 Dec;23(6):511. doi: 10.1007/s10637-005-4018-2. Invest New Drugs. 2005. PMID: 16391895 No abstract available.
-
Review of studies of selected metabolic polymorphisms and cancer.IARC Sci Publ. 1999;(148):323-93. IARC Sci Publ. 1999. PMID: 10493265 Review. No abstract available.
-
Genetic testing for pharmacogenetics and its clinical application in drug therapy.Clin Chim Acta. 2006 Jan;363(1-2):177-86. doi: 10.1016/j.cccn.2005.05.047. Epub 2005 Aug 26. Clin Chim Acta. 2006. PMID: 16126184 Review.
-
Drug methylation in cancer therapy: lessons from the TPMT polymorphism.Oncogene. 2003 Oct 20;22(47):7403-13. doi: 10.1038/sj.onc.1206944. Oncogene. 2003. PMID: 14576848 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
